| IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma S Hu, X Wu, B Zhou, Z Xu, J Qin, H Lu, L Lv, Y Gao, L Deng, J Yin, G Li Journal of cancer research and clinical oncology 140, 883-893, 2014 | 187 | 2014 |
| Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial X Chen, X Wu, H Wu, Y Gu, Y Shao, Q Shao, F Zhu, X Li, X Qian, J Hu, ... Journal for immunotherapy of cancer 8 (2), 2020 | 110 | 2020 |
| Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion X Wu, J Fan, X Wang, J Zhou, S Qiu, Y Yu, Y Liu, Z Tang Biochemical and biophysical research communications 355 (4), 866-871, 2007 | 73 | 2007 |
| Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma X Wu, H Chen, Q Gao, J Bai, X Wang, J Zhou, S Qiu, Y Xu, Y Shi, X Wang, ... Molecular carcinogenesis 53 (4), 325-336, 2014 | 28 | 2014 |
| Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma G Li, X Wu, F Zhang, X Li, B Sun, Y Yu, A Yin, L Deng, J Yin, X Wang Journal of cancer research and clinical oncology 137, 695-703, 2011 | 27 | 2011 |
| Safety and efficacy of sintilimab and anlotinib as first line treatment for advanced hepatocellular carcinoma (KEEP-G04): a single-arm phase 2 study X Chen, W Li, X Wu, F Zhao, D Wang, H Wu, Y Gu, X Li, X Qian, J Hu, C Li, ... Frontiers in Oncology 12, 909035, 2022 | 26 | 2022 |
| PSMC2 regulates cell cycle progression through the p21/cyclin D1 pathway and predicts a poor prognosis in human hepatocellular carcinoma Y Liu, H Chen, X Li, F Zhang, L Kong, X Wang, J Bai, X Wu Frontiers in Oncology 11, 607021, 2021 | 12 | 2021 |
| LncRNA LINC00460 facilitates the proliferation and metastasis of renal cell carcinoma via PI3K/AKT signaling pathway FJ Zhou, S Meng, XF Wu, PF Hou, ML Li, SF Chu, J Bai, JN Zheng Journal of Cancer 13 (9), 2844, 2022 | 4 | 2022 |
| Copper transporter gene ATP7A: a predictive biomarker for immunotherapy and targeted therapy in hepatocellular carcinoma K Shao, H Shen, X Chen, Z Shao, Y Liu, Y Wang, H Chen, X Wu International Immunopharmacology 114, 109518, 2023 | 3 | 2023 |
| Immuno-genomic-radiomics to predict response of biliary tract cancer to camrelizumab plus GEMOX in a single-arm phase II trial QP Liu, J Tang, YZ Chen, F Guo, L Ma, LL Pan, YT Tian, XF Wu, ... JHEP Reports 5 (7), 100763, 2023 | 1 | 2023 |
